312 related articles for article (PubMed ID: 33036018)
1. Clinical and molecular characteristics of carbapenem non-susceptible Escherichia coli: A nationwide survey from Oman.
Al-Farsi HM; Camporeale A; Ininbergs K; Al-Azri S; Al-Muharrmi Z; Al-Jardani A; Giske CG
PLoS One; 2020; 15(10):e0239924. PubMed ID: 33036018
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.
Alsharapy SA; Gharout-Sait A; Muggeo A; Guillard T; Cholley P; Brasme L; Bertrand X; Moghram GS; Touati A; De Champs C
Microb Drug Resist; 2020 Mar; 26(3):211-217. PubMed ID: 31397629
[No Abstract] [Full Text] [Related]
3. Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran.
Hojabri Z; Mirmohammadkhani M; Kamali F; Ghassemi K; Taghavipour S; Pajand O
Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1859-1866. PubMed ID: 28550370
[TBL] [Abstract][Full Text] [Related]
4. Emergence of carbapenem resistant Escherichia coli isolates producing bla
Solgi H; Giske CG; Badmasti F; Aghamohammad S; Havaei SA; Sabeti S; Mostafavizadeh K; Shahcheraghi F
Infect Genet Evol; 2017 Nov; 55():318-323. PubMed ID: 28987805
[TBL] [Abstract][Full Text] [Related]
5. Dissemination of an international high-risk clone of Escherichia coli ST410 co-producing NDM-5 and OXA-181 carbapenemases in Seoul, Republic of Korea.
Kim JS; Yu JK; Jeon SJ; Park SH; Han S; Park SH; Kang M; Jang JI; Park J; Shin EK; Kim J; Hong CK; Lee JH; Hwang YO; Oh YH
Int J Antimicrob Agents; 2021 Dec; 58(6):106448. PubMed ID: 34648943
[TBL] [Abstract][Full Text] [Related]
6. First report of the new emerging global clone ST1193 among clinical isolates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli from Germany.
Valenza G; Werner M; Eisenberger D; Nickel S; Lehner-Reindl V; Höller C; Bogdan C
J Glob Antimicrob Resist; 2019 Jun; 17():305-308. PubMed ID: 30682563
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
Papagiannitsis CC; Študentová V; Jakubů V; Španělová P; Urbášková P; Žemličková H; Hrabák J
Microb Drug Resist; 2015 Feb; 21(1):74-84. PubMed ID: 25188031
[TBL] [Abstract][Full Text] [Related]
8. A Decade-Long Evaluation of Neonatal Septicaemic Escherichia coli: Clonal Lineages, Genomes, and New Delhi Metallo-Beta-Lactamase Variants.
Bhattacharjee A; Sands K; Mitra S; Basu R; Saha B; Clermont O; Dutta S; Basu S
Microbiol Spectr; 2023 Aug; 11(4):e0521522. PubMed ID: 37367488
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Carbapenem-Resistant Escherichia coli Isolates Through the Whole-Genome Sequencing Analysis.
Luo Y; Luo R; Ding H; Ren X; Luo H; Zhang Y; Ye L; Cui S
Microb Drug Resist; 2018 Mar; 24(2):175-180. PubMed ID: 28686503
[TBL] [Abstract][Full Text] [Related]
10. Emergence of diversity in carbapenemase-producing
Ellaby N; Doumith M; Hopkins KL; Woodford N; Ellington MJ
Euro Surveill; 2019 Sep; 24(37):. PubMed ID: 31530344
[TBL] [Abstract][Full Text] [Related]
11. Cross-border emergence of clonal lineages of ST38 Escherichia coli producing the OXA-48-like carbapenemase OXA-244 in Germany and Switzerland.
Falgenhauer L; Nordmann P; Imirzalioglu C; Yao Y; Falgenhauer J; Hauri AM; Heinmüller P; Chakraborty T
Int J Antimicrob Agents; 2020 Dec; 56(6):106157. PubMed ID: 32919009
[TBL] [Abstract][Full Text] [Related]
12. Characterization of NDM-7 Carbapenemase-Producing Escherichia coli Isolates in the Arabian Peninsula.
Pál T; Ghazawi A; Darwish D; Villa L; Carattoli A; Hashmey R; Aldeesi Z; Jamal W; Rotimi V; Al-Jardani A; Al-Abri SS; Sonnevend Á
Microb Drug Resist; 2017 Oct; 23(7):871-878. PubMed ID: 28156193
[TBL] [Abstract][Full Text] [Related]
13. Hidden Carbapenem Resistance in OXA-48 and Extended-Spectrum β-Lactamase-Positive
Tomić Paradžik M; Drenjančević D; Presečki-Stanko A; Kopić J; Talapko J; Zarfel G; Bedenić B
Microb Drug Resist; 2019 Jun; 25(5):696-702. PubMed ID: 30614759
[TBL] [Abstract][Full Text] [Related]
14. Emergence and transmission of New Delhi metallo-beta-lactamase-5-producing Escherichia coli Sequence Type 361 in a Tertiary Hospital in South Korea.
Park Y; Choi Q; Kwon GC; Koo SH
J Clin Lab Anal; 2020 Feb; 34(2):e23041. PubMed ID: 31541503
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of Carbapenem resistant Escherichia coli recovered from a tertiary hospital in Lebanon.
Dagher C; Salloum T; Alousi S; Arabaghian H; Araj GF; Tokajian S
PLoS One; 2018; 13(9):e0203323. PubMed ID: 30188911
[TBL] [Abstract][Full Text] [Related]
16. Multicentre investigation of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Bulgarian hospitals - Interregional spread of ST11 NDM-1-producing K. pneumoniae.
Markovska R; Stoeva T; Boyanova L; Stankova P; Schneider I; Keuleyan E; Mihova K; Murdjeva M; Sredkova M; Lesseva M; Nedelcheva G; Petrova A; Ivanova D; Lazarova G; Kaneva R; Mitov I
Infect Genet Evol; 2019 Apr; 69():61-67. PubMed ID: 30654179
[TBL] [Abstract][Full Text] [Related]
17. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
[TBL] [Abstract][Full Text] [Related]
18. Plasmid analysis of Escherichia coli isolates from South Korea co-producing NDM-5 and OXA-181 carbapenemases.
Baek JY; Cho SY; Kim SH; Kang CI; Peck KR; Song JH; Chung DR; Ko KS
Plasmid; 2019 Jul; 104():102417. PubMed ID: 31150689
[TBL] [Abstract][Full Text] [Related]
19. CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain.
Merino I; Shaw E; Horcajada JP; Cercenado E; Mirelis B; Pallarés MA; Gómez J; Xercavins M; Martínez-Martínez L; De Cueto M; Cantón R; Ruiz-Garbajosa P;
J Antimicrob Chemother; 2016 Aug; 71(8):2125-30. PubMed ID: 27494832
[TBL] [Abstract][Full Text] [Related]
20. Genomic Analysis of Multidrug-Resistant Escherichia coli from North Carolina Community Hospitals: Ongoing Circulation of CTX-M-Producing ST131-
Kanamori H; Parobek CM; Juliano JJ; Johnson JR; Johnston BD; Johnson TJ; Weber DJ; Rutala WA; Anderson DJ
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584139
[No Abstract] [Full Text] [Related]
[Next] [New Search]
